BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 30217622)

  • 21. Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey.
    Saliba G; Detlefsen S; Carneiro F; Conner J; Dorer R; Fléjou JF; Hahn H; Kamaradova K; Mastracci L; Meijer SL; Sabo E; Sheahan K; Riddell R; Wang N; Yantiss RK; Lundell L; Low D; Vieth M; Klevebro F
    Hum Pathol; 2021 Feb; 108():60-67. PubMed ID: 33221343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes.
    Tsekrekos A; Vieth M; Ndegwa N; Bateman A; Flejou JF; Grabsch HI; Mastracci L; Meijer SL; Saragoni L; Sheahan K; Shetye J; Yantiss R; Lundell L; Detlefsen S
    Hum Pathol; 2021 Oct; 116():94-101. PubMed ID: 34284051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
    Becker K; Mueller JD; Schulmacher C; Ott K; Fink U; Busch R; Böttcher K; Siewert JR; Höfler H
    Cancer; 2003 Oct; 98(7):1521-30. PubMed ID: 14508841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey.
    Westerhoff M; Osecky M; Langer R
    Mod Pathol; 2020 Apr; 33(4):676-689. PubMed ID: 31673084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathologic tumor regression grading in patients with gastric carcinoma submitted to neoadjuvant treatment: results of a Delphi survey.
    Tsekrekos A; Detlefsen S; Riddell R; Conner J; Mastracci L; Sheahan K; Shetye J; Lundell L; Vieth M
    Hum Pathol; 2019 Feb; 84():26-34. PubMed ID: 30217622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Connection and distinction of tumor regression grading systems of gastrointestinal cancer.
    Tong Y; Liu D; Zhang J
    Pathol Res Pract; 2020 Sep; 216(9):153073. PubMed ID: 32825946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of the lymph nodes in penile cancer.
    Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
    Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical review.
    Neves Filho EH; de Sant'Ana RO; Nunes LV; Pires AP; da Cunha MD
    APMIS; 2017 Feb; 125(2):79-84. PubMed ID: 28044374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.
    Langer R; Becker K
    Virchows Arch; 2018 Feb; 472(2):175-186. PubMed ID: 28918544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Grading of tumor regression of gastrointestinal carcinomas after neoadjuvant therapy].
    Liu D; Langer R
    Pathologe; 2022 Feb; 43(1):51-56. PubMed ID: 34940918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A Case of Gastric Cancer Responding to Neoadjuvant Chemotherapy Leading to Histological Change to Grade 3].
    Osakabe H; Katayanagi S; Makuuchi Y; Shigoka M; Sumi T; Tsuchida A; Kawachi S
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2228-2230. PubMed ID: 28133278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues.
    Chang F; Deere H; Mahadeva U; George S
    Am J Clin Pathol; 2008 Feb; 129(2):252-62. PubMed ID: 18208806
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.